TrialDiabetes care2013

Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatment.

Helen L Barrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.